AMPIO PHARMACEUTICALS Stock Price
$5.05 
Change:
-0.04 -0.39% Volume:
3,400
Live Stock Prices
You need Flash Player to see the chart, please download from the link below
Todays Chart
You need Flash Player to see the chart, please download from the link below
Month Chart
Todays High: 5.09 | Todays Low: 5.01 | Open: 5.09 | Last Close: 5.07
52 Wk High: 6.18 | 52 Wk Low: 2.55 | Todays Pivot: 5.05 | Pre market open: 4.71
Sector: 
Online News For AMPIO PHARMACEUTICALS
|
Comstock Holding Companies Inc (NASDAQ:CHCI) bounces back, Ampio ... - NIS
Wed, 22 May 2013 04:08Ampio Pharmaceuticals, Inc (NASDAQ:AMPE): In Tuesday's trading session, Ampio Pharmaceuticals, Inc (NASDAQ:AMPE) up by 3.21%. Its opening price of $4.66 rose to touch an intraday high of $4.84 which eventually headed down to close at $4.82 per ...
|
|
Ampio Pharmaceuticals Announces Participation at the UBS Global Healthcare ... - MarketWatch (press release)
Mon, 13 May 2013 12:03Ampio Pharmaceuticals, Inc. is a biopharmaceutical company focused on the rapid development of therapies to treat prevalent inflammatory conditions for which there are limited treatment options. It aims to provide medicines to improve the health and ...
|
|
Ampio Pharmaceuticals Completes Enrollment in Run-In SPRING study of ... - PR Newswire (press release)
Thu, 25 Apr 2013 12:02GREENWOOD VILLAGE, Colo., April 25, 2013 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NASDAQ: AMPE) today announced the completion of patient enrollment in a dose-escalation run-in study to a Phase III pivotal trial evaluating Ampion in the ...
|
|
Ampio Pharma Initiates Phase III, Investors Extend Momentum - Seeking Alpha
Fri, 03 May 2013 13:43Shares of Ampio Pharmaceuticals (NASDAQ: AMPE) are on a roll after the company reported on April 24th that it completed enrollment for its Phase III run-in trial with Ampion, a naturally occurring anti-inflammatory compound that is under development ...
|
|
Regeneron Shareholders Watching Optina Trial Closely - Seeking Alpha
Wed, 22 May 2013 19:57Optina is a pill being developed by Ampio Pharmaceuticals, Inc. (AMPE) and it works with an entirely different mechanism where it actually repairs the leaking blood vessels by restoring the cytoskeletal system of the cells making up the leaking blood ...
|
|
Ampio completes patient enrollment in dose-escalation run-in study of Ampion ... - News-Medical.net
Fri, 26 Apr 2013 14:33Ampio Pharmaceuticals, Inc. (NASDAQ: AMPE) today announced the completion of patient enrollment in a dose-escalation run-in study to a Phase III pivotal trial evaluating Ampion in the treatment of moderate to severe osteoarthritis of the knee. Twelve ...
|
AMPE Chart
You need Flash Player to see the chart, please download from the link below
Want To Add This Quote To Your Site?
With our stock widgets you can add a real time AMPIO PHARMACEUTICALS quote to your website to keep your users up to date with the market. We have a variety of different styled widgets for AMPE to choose from. Visit here to build your stock quote widget »
